Inventor · disambiguated record
Eve Montia
Also filed as: MONTIA EVE
11 granted patents·14 pending applications·21 citations·filing 2006–2024
86Inventor score
Top patents by PatentIndex Score
25 records- 0191US11986489B2Method of treating a disease using a glycolytic dependent compoundETHICON INC·Filed 2021·Granted May 21, 2024·2 cites·3 claims
- 0285US8415455B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2008·Granted Apr 9, 2013·9 cites·14 claims
- 0384US9107862B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Aug 18, 2015·5 cites·9 claims
- 0481US9375466B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Jun 28, 2016·3 cites·4 claims
- 0579US2024285834A1Compositions Comprising Oxidized CelluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0674US9555087B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2014·Granted Jan 31, 2017·1 cites·27 claims
- 0773US10098934B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Oct 16, 2018·1 cites·9 claims
- 0870US11690937B2Antimicrobial compositions comprising minocycline and degradation products of oxidized celluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted Jul 4, 2023·0 cites·5 claims
- 0969US11654217B2Antimicrobial compositions comprising minocycline and oxidized celluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted May 23, 2023·0 cites·8 claims
- 1069US2011311450A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2009·Application pending·0 cites
- 1166US11045588B2Antimicrobial compositions comprising minocycline and degradation products of oxidized celluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2018·Granted Jun 29, 2021·0 cites·10 claims
- 1266US11000635B2Antimicrobial compositions comprising minocycline and oxidized celluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2018·Granted May 11, 2021·0 cites·7 claims
- 1363US2018298109A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2018·Application pending·0 cites
- 1463US2020139021A1Compositions Comprising Oxidized CelluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 1561US2020261492A1Compositions Comprising Oxidized CelluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1658US2017037141A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 1757US2011052501A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsDASSA LIAT·Filed 2009·Application pending·0 cites
- 1856US2022054527A1Method of treating a disease using a glycolytic dependent compoundETHICON INC·Filed 2021·Application pending·0 cites
- 1956US2016068606A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2015·Application pending·0 cites
- 2055US2017107284A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 2152US2016177395A1Biomarkers for the prediction of renal injuryCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 2251US10960021B2Method of treating a disease using a glycolytic dependent compoundETHICON INC·Filed 2016·Granted Mar 30, 2021·0 cites·3 claims
- 2349US2013315819A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Application pending·0 cites
- 2445US2009275021A1Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosisSELLA-TAVOR OSNAT·Filed 2006·Application pending·0 cites
- 2544US2011003708A1Biomarkers for the prediction of renal injuryCOMPUGEN LTD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eve Montia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →